Actos

Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out

Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out

Bloomberg

Jury hits Takeda with $6.5M judgment in first Actos liability case

Jury hits Takeda with $6.5M judgment in first Actos liability case

Fierce Pharma

Takeda Put Actos Sales Ahead of User Safety, Witness Says

Takeda Put Actos Sales Ahead of User Safety, Witness Says

Bloomberg

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

Bloomberg

Takeda Worried About Actos’s Cancer Link, Filing Shows

Takeda Worried About Actos’s Cancer Link, Filing Shows

BusinessWeek

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Bloomberg

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Bloomberg

Watson Receives FDA Approval for Generic Actos®

Watson Receives FDA Approval for Generic Actos®

Equities.com

Watson Pharma Sues FDA

Watson Pharma Sues FDA

Zacks

Takeda's Actos era ends with generic launches

Takeda's Actos era ends with generic launches

Fierce Pharma